Participant flow20

How many started, completed or left each group, period by period.

1 to 20 of 20

Period	Milestone	Group	Participants
Overall Study	STARTED	High Dose	172
Overall Study	STARTED	Intermediate Dose	172
Overall Study	STARTED	Low Dose	173
Overall Study	STARTED	Allopurinol	171
Overall Study	STARTED	Placebo	173
Overall Study	Switch Dose	High Dose	0
Overall Study	Switch Dose	Intermediate Dose	0
Overall Study	Switch Dose	Low Dose	37
Overall Study	Switch Dose	Allopurinol	0
Overall Study	Switch Dose	Placebo	0
Overall Study	COMPLETED	High Dose	137
Overall Study	COMPLETED	Intermediate Dose	143
Overall Study	COMPLETED	Low Dose	131
Overall Study	COMPLETED	Allopurinol	145
Overall Study	COMPLETED	Placebo	147
Overall Study	NOT COMPLETED	High Dose	35
Overall Study	NOT COMPLETED	Intermediate Dose	29
Overall Study	NOT COMPLETED	Low Dose	42
Overall Study	NOT COMPLETED	Allopurinol	26
Overall Study	NOT COMPLETED	Placebo	26

Source ClinicalTrials.govtrials-2026-11-12-0.4.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNone stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT03990363/flow